Albany Molecular Research (AMRI)
Albany Molecular Research Historical Price Data
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 25, 2012 | 2.75 | 2.85 | 2.70 | 2.71 | 111827 |
| May 24, 2012 | 2.81 | 2.83 | 2.74 | 2.76 | 36383 |
| May 23, 2012 | 2.83 | 2.94 | 2.80 | 2.81 | 88552 |
| May 22, 2012 | 2.91 | 2.91 | 2.83 | 2.85 | 62889 |
| May 21, 2012 | 3.01 | 3.01 | 2.87 | 2.92 | 74495 |
| May 18, 2012 | 2.96 | 3.030 | 2.96 | 3.01 | 166494 |
| May 17, 2012 | 3.01 | 3.05 | 2.95 | 2.97 | 92245 |
| May 16, 2012 | 3.05 | 3.09 | 3.01 | 3.01 | 119487 |
| May 15, 2012 | 3.00 | 3.11 | 3.00 | 3.05 | 100346 |
| May 14, 2012 | 3.01 | 3.05 | 3.01 | 3.01 | 75119 |
| May 11, 2012 | 3.03 | 3.10 | 3.01 | 3.04 | 67681 |
| May 10, 2012 | 3.03 | 3.14 | 2.98 | 3.06 | 61714 |
| May 9, 2012 | 3.00 | 3.10 | 3.00 | 3.01 | 104600 |
| May 8, 2012 | 3.01 | 3.04 | 3.01 | 3.01 | 52131 |
| May 7, 2012 | 3.00 | 3.05 | 3.00 | 3.03 | 24948 |
| May 4, 2012 | 3.00 | 3.15 | 3.00 | 3.01 | 67494 |
| May 3, 2012 | 3.08 | 3.08 | 3.00 | 3.01 | 114083 |
| May 2, 2012 | 3.05 | 3.14 | 3.02 | 3.09 | 44671 |
| May 1, 2012 | 3.18 | 3.38 | 3.07 | 3.08 | 93813 |
| April 30, 2012 | 3.17 | 3.30 | 3.15 | 3.19 | 100147 |
| April 27, 2012 | 3.18 | 3.22 | 3.05 | 3.18 | 96974 |
| April 26, 2012 | 3.35 | 3.35 | 3.11 | 3.17 | 236205 |
| April 25, 2012 | 3.07 | 3.44 | 3.07 | 3.36 | 206376 |
| April 24, 2012 | 2.92 | 3.07 | 2.90 | 3.03 | 76776 |
| April 23, 2012 | 2.90 | 3.01 | 2.88 | 2.92 | 67459 |
| April 20, 2012 | 2.95 | 3.06 | 2.91 | 2.95 | 95516 |
| April 19, 2012 | 2.94 | 2.95 | 2.88 | 2.90 | 46725 |
| April 18, 2012 | 3.06 | 3.06 | 2.88 | 2.94 | 65972 |
| April 17, 2012 | 2.83 | 3.07 | 2.80 | 3.06 | 108961 |
| April 16, 2012 | 2.80 | 2.858 | 2.76 | 2.80 | 33679 |
| April 13, 2012 | 2.75 | 2.83 | 2.73 | 2.80 | 61758 |
| April 12, 2012 | 2.79 | 2.83 | 2.75 | 2.77 | 39318 |
| April 11, 2012 | 2.81 | 2.85 | 2.76 | 2.80 | 71197 |
| April 10, 2012 | 2.84 | 2.920 | 2.74 | 2.77 | 91582 |
| April 9, 2012 | 2.80 | 2.90 | 2.71 | 2.85 | 88326 |
| April 5, 2012 | 2.77 | 2.929 | 2.77 | 2.84 | 53631 |
| April 4, 2012 | 2.71 | 2.83 | 2.68 | 2.79 | 82899 |
| April 3, 2012 | 2.71 | 2.88 | 2.71 | 2.74 | 39247 |
| April 2, 2012 | 2.72 | 2.83 | 2.66 | 2.70 | 156453 |
| March 30, 2012 | 2.80 | 2.86 | 2.70 | 2.70 | 74062 |
| March 29, 2012 | 2.85 | 2.89 | 2.76 | 2.77 | 72853 |
| March 28, 2012 | 2.93 | 2.94 | 2.86 | 2.87 | 63208 |
| March 27, 2012 | 3.09 | 3.110 | 2.90 | 2.92 | 87938 |
| March 26, 2012 | 2.86 | 3.10 | 2.84 | 3.09 | 204084 |
| March 23, 2012 | 2.76 | 2.85 | 2.68 | 2.84 | 335890 |
| March 22, 2012 | 2.66 | 2.72 | 2.66 | 2.71 | 104721 |
| March 21, 2012 | 2.66 | 2.66 | 2.66 | 2.66 | 0.00 |
| March 20, 2012 | 2.75 | 2.77 | 2.65 | 2.66 | 270095 |
| March 19, 2012 | 2.77 | 2.96 | 2.73 | 2.76 | 195655 |
| March 16, 2012 | 2.81 | 2.89 | 2.72 | 2.77 | 110272 |
AMRI News
Listen to $AMRI Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3k43
about 18 days ago by earningscast
about 18 days ago by earningscast
I need all the ones that horizon Alerted recently that im currently stuck in way down $RCON $AMRI $NFC $SINO and more to go up a lot
about 23 days ago by epime7heus
about 23 days ago by epime7heus
AMRI Launches SMARTSOURCING™ For Contract Manufacturing and Research Services
Apr 30, 8:00AM PR Newswire
Apr 30, 8:00AM PR Newswire
AMRI Announces Development and Manufacturing Deal with Biota Holdings Limited
Apr 17, 8:00AM PR Newswire
Apr 17, 8:00AM PR Newswire
AMRI Signs Exclusive Option to License its Tubulin Inhibitor Program for Cancer
Apr 03, 8:01AM Benzinga
Apr 03, 8:01AM Benzinga
AMRI Hires Senior Manager to Oversee Facilities at Burlington Aseptic Fill Operations
Mar 27, 8:00AM PR Newswire
Mar 27, 8:00AM PR Newswire
Albany Molecular Research (AMRI) Reports Q4 Loss of $0.19; Guides Contract Revs
Feb 07, 8:05AM Street Insider
Feb 07, 8:05AM Street Insider
AMRI CFO to Present at UBS 22nd Annual Global Healthcare Services Conference
Feb 01, 8:00AM PR Newswire
Feb 01, 8:00AM PR Newswire
Albany Molecular (AMRI) Announces Workforce Reduction, to Cease Facility Lease; Updates on Expected Charges
Dec 22, 5:08PM Street Insider
Dec 22, 5:08PM Street Insider
Insider Cluster-Buying At $AMRI. 23,900 shares purchased. http://stks.co/1Xse
about 165 days ago by abubnic
about 165 days ago by abubnic
Sterne Agee reiterated its “Buy” rating on $AMRI with a price target of $7.00.
about 165 days ago by abubnic
about 165 days ago by abubnic
$AMRI $5.00 Hagen Steven R officer (VP Pharmaceutical Dev & Mfg) S 198 @ $4.84 amnt $958 proc'd ($32) 5/6/2011
about 381 days ago by canarionyc
about 381 days ago by canarionyc
$AMRI http://chart.ly/xvpba4r Closed above 50 day on high volume, 10% of float is short, MACD looks ready
about 405 days ago by Tr8r_x
about 405 days ago by Tr8r_x
$AMRI discloses court ruling related to $RDY and 24-hour Allegra case. http://bit.ly/gkba7y
about 485 days ago by TradeHawk
about 485 days ago by TradeHawk
$AMRI Hagen Steven R officer (VP Pharmaceutical Dev & Mfg) sold 2,000 @ $5.20 totl $10,400.00 2010-12-06
about 524 days ago by canarionyc
about 524 days ago by canarionyc
start swing long 1k $AMRI on long time coming trend reversal, looking for 6.3 stop 5.3
about 709 days ago by Assailed
about 709 days ago by Assailed
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AMRI | 2.71 | -0.05 | -1.81% | 83.39M |
| AMRC | 11.07 | -0.15 | -1.34% | 289.15M |
| AMPL | 0.185 | +0.01 | +2.83% | 10.38M |
| ALVR | 0.49 | +0.03 | +6.52% | 28.41M |
| ALV | 57.16 | -0.25 | -0.44% | 5.116B |
| ALU | 1.67 | +0.07 | +4.38% | 3.883B |
| ALTR | 34.42 | +0.66 | +1.96% | 11.11B |
| ALTI | 0.66 | +0.00 | +0.00% | 45.84M |
| ALTH | 1.80 | +0.00 | +0.00% | 192.53M |
| ALTE | 22.72 | -0.28 | -1.22% | 2.292B |